We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$685M
2
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$54.5M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$42.1M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$27.7M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Financials 11.56%
3 Healthcare 11.43%
4 Consumer Discretionary 10.98%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SURF
2876
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$68K ﹤0.01%
8,683
-2,004
-19% -$20K
RMO
2877
DELISTED
Romeo Power, Inc.
RMO
$68K ﹤0.01%
8,133
+3,575
+78% +$56.4K
SOLN
2878
DELISTED
The Southern Company
SOLN
$68K ﹤0.01%
+1,328
New +$66.7K
AMRX icon
2879
Amneal Pharmaceuticals
AMRX
$6.15B
$67K ﹤0.01%
9,959
-32,711
-77% -$181K
CPRX
2880
DELISTED
Catalyst Pharmaceutical
CPRX
$67K ﹤0.01%
14,446
+5,467
+61% +$21.7K
GOOD
2881
Gladstone Commercial Corp
GOOD
$641M
$67K ﹤0.01%
3,416
+819
+32% +$15.5K
KWEB icon
2882
KraneShares CSI China Internet ETF
KWEB
$5.31B
$67K ﹤0.01%
870
-1,237
-59% -$108K
NKTX icon
2883
Nkarta
NKTX
$165M
$67K ﹤0.01%
2,025
+1,617
+396% +$77.3K
SDD icon
2884
ProShares UltraShort SmallCap600
SDD
$1.3M
$67K ﹤0.01%
2,481
-955
-28% -$29K
STRL icon
2885
Sterling Infrastructure
STRL
$16.9B
$67K ﹤0.01%
2,871
+955
+50% +$20.8K
UYG icon
2886
ProShares Ultra Financials
UYG
$863M
$67K ﹤0.01%
1,274
-36,695
-97% -$1.75M
VIV icon
2887
Telefônica Brasil
VIV
$18.1B
$67K ﹤0.01%
7,986
-2,026
-20% -$16.9K
LGF.A
2888
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$67K ﹤0.01%
4,523
-6,327
-58% -$94.9K
EQOS
2889
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$67K ﹤0.01%
6,151
-8,171
-57% -$124K
SOGO
2890
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$67K ﹤0.01%
8,888
+7,389
+493% +$61K
AXDX
2891
DELISTED
Accelerate Diagnostics
AXDX
$66K ﹤0.01%
788
+590
+298% +$59.9K
BNED icon
2892
Barnes & Noble Education
BNED
$417M
$66K ﹤0.01%
80
-83
-51% -$57.1K
BNTX icon
2893
BioNTech
BNTX
$23.1B
$66K ﹤0.01%
608
-8,351
-93% -$887K
GRC icon
2894
Gorman-Rupp
GRC
$2.15B
$66K ﹤0.01%
1,982
-7,580
-79% -$251K
IBUY icon
2895
Amplify Online Retail ETF
IBUY
$125M
$66K ﹤0.01%
+530
New +$67.9K
LE icon
2896
Lands' End
LE
$391M
$66K ﹤0.01%
2,674
+1,870
+233% +$54.8K
QUAD icon
2897
Quad
QUAD
$507M
$66K ﹤0.01%
18,763
-1,002
-5% -$4.77K
RBCAA icon
2898
Republic Bancorp
RBCAA
$1.91B
$66K ﹤0.01%
1,482
-2,633
-64% -$109K
VNRX icon
2899
VolitionRx Ltd
VNRX
$7.6M
$66K ﹤0.01%
875
+656
+300% +$56.3K
NBSE
2900
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$66K ﹤0.01%
446
+166
+59% +$30.1K
114 115
116
117 118

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.